Silverarc Capital Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Silverarc Capital Management’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-192,995	Closed	-$1.41M	–	109
2022 Q4	$1.41M	Buy	192,995 +4,695	+2%	+$33.1K	0.49%	62
2022 Q3	$1.3M	Buy	188,300 +11,991	+7%	+$89.5K	0.55%	56
2022 Q2	$1.23M	Buy	176,309 +23,042	+15%	+$180K	0.58%	50
2022 Q1	$1.27K	Sell	153,267 -196,946	-56%	-$1.78M	0.6%	48
2021 Q4	$3.78M	Sell	350,213 -166,008	-32%	-$1.79M	1.69%	20
2021 Q3	$6.22M	Buy	516,221 +59,684	+13%	+$674K	3.6%	5
2021 Q2	$5.54K	Buy	456,537 +26,674	+6%	+$331K	2.7%	8
2021 Q1	$5.99M	Buy	429,863 +27,307	+7%	+$382K	3.36%	5
2020 Q4	$5.7M	Buy	+402,556	New	+$5.25M	3.48%	6

Other funds holding AMYT

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return

TIG Advisors LLC New York $2.09B AUM 72.99% 1-Year Est. Return

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return